These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9701378)

  • 21. [Monitoring of renal function in epileptic children and teenagers treated with valproic acid or carbamazepine in concomitant therapy with tiagabine].
    Hurkacz M; Wiela-Hojeńska A; Orzechowska-Juzwenko K; Kozik A; Unolt J
    Pol Merkur Lekarski; 2001 Dec; 11(66):480-3. PubMed ID: 11899842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term safety of tiagabine.
    Kälviäinen R
    Epilepsia; 2001; 42 Suppl 3():46-8. PubMed ID: 11520323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical implications of pharmacology and pharmacokinetics of tiagabine].
    Pita-Calandre E
    Rev Neurol; 1999 Feb 1-15; 28(3):337-9. PubMed ID: 10714305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy].
    Kozik A; Krause M
    Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures.
    Borowicz KK; Zadrozniak M; Luszczki JJ; Czuczwar SJ
    J Neural Transm (Vienna); 2008 May; 115(5):661-7. PubMed ID: 18193378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function.
    Lau AH; Gustavson LE; Sperelakis R; Lam NP; El-Shourbagy T; Qian JX; Layden T
    Epilepsia; 1997 Apr; 38(4):445-51. PubMed ID: 9118850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tiagabine: the safety landscape.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 6():S10-S13. PubMed ID: 8595787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat.
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2004 May; 45(5):424-35. PubMed ID: 15101823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy.
    Morimoto K; Sato H; Yamamoto Y; Watanabe T; Suwaki H
    Epilepsia; 1997 Sep; 38(9):966-74. PubMed ID: 9579934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient dystonias in three patients treated with tiagabine.
    Wolańczyk T; Grabowska-Grzyb A
    Epilepsia; 2001 Jul; 42(7):944-6. PubMed ID: 11488897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy.
    Adkins JC; Noble S
    Drugs; 1998 Mar; 55(3):437-60. PubMed ID: 9530548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiagabine.
    Shinnar S
    Semin Pediatr Neurol; 1997 Mar; 4(1):24-33. PubMed ID: 9097364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years.
    Mikaeloff Y; Rey E; Soufflet C; d'Athis P; Echenne B; Vallée L; Bouhours P; Grinspan A; Dulac O; Pons G; Chiron C
    Epilepsia; 2004 Nov; 45(11):1448-52. PubMed ID: 15509246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between anticonvulsants and human placental carnitine transporter.
    Wu SP; Shyu MK; Liou HH; Gau CS; Lin CJ
    Epilepsia; 2004 Mar; 45(3):204-10. PubMed ID: 15009220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetic inter-relationship of tiagabine in blood, cerebrospinal fluid and brain extracellular fluid (frontal cortex and hippocampus).
    Wang X; Ratnaraj N; Patsalos PN
    Seizure; 2004 Dec; 13(8):574-81. PubMed ID: 15519917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamic analysis of the interaction between tiagabine and midazolam with an allosteric model that incorporates signal transduction.
    Jonker DM; Vermeij DA; Edelbroek PM; Voskuyl RA; Piotrovsky VK; Danhof M
    Epilepsia; 2003 Mar; 44(3):329-38. PubMed ID: 12614388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.